Carcinosarcoma of the breast with massive osseous malignant component: a basal-like entity with myoepithelial differentiation

1. Moinfar F.: Essentials of diagnostic breast pathologya practical approach. Springer; 2007: 234-236Search in Google Scholar

2. Ninomiya J, Oyama T, Horiguchi J, Koibuchi Y, Yoshida T, Iijima K et al: Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer. 2005;12(1):52-6.10.2325/jbcs.12.5215657524Search in Google Scholar

3. Kijima Y, Umekita Y, Yoshinaka H, Owaki T, Sakamoto A, Yoshida H et al: A case of breast carcinoma with cartilaginous and osseous metaplasia. Breast Cancer. 2006;13(2):214-9.10.2325/jbcs.13.21416755121Search in Google Scholar

4. Rosen PP.: Rosen’s breast pathology. 2nd ed. Philadelphia, PA: Lippincott- Williams&Wilkins; 2001: 425-452Search in Google Scholar

5. Tavassoli FA, Devilee P.: Tumours of the breast and female genital organs. Lyon, France, IARC Press; 2003: p 37-41Search in Google Scholar

6. Tavassoli Fattaneh: Pathology of the breast. Hong- Kong, McGraw-Hill Professional, 1999: p 504Search in Google Scholar

7. An T., Grathwohl M., Frabe W.J.: Breat carcinoma with osseous metaplasia: An electron microscopic study. Am.J.Clin.Pathol., 1984, 81: 127-13210.1093/ajcp/81.1.1276318548Search in Google Scholar

8. Chhieng C, Cranor M, Lesser ME, Rosen PP.: Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol. 1998 Feb;22(2):188-94.10.1097/00000478-199802000-000069500219Search in Google Scholar

9. Tavassoli Fattaneh: Pathology of the breast. Hong- Kong, McGraw-Hill Professional, 1999: p 614Search in Google Scholar

10. Carter MR, Hornick JL, Lester S, Fletcher CD.: Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006 Mar;30(3):300-9.10.1097/01.pas.0000184809.27735.a116538049Search in Google Scholar

11. Rungta S, Kleer CG.: Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights. Arch Pathol Lab Med. 2012 Aug;136(8):896-90010.5858/arpa.2012-0166-CR390664122849737Search in Google Scholar

12. Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH et al: The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Cancer Res Treat. 2011 Apr;126(2):471-810.1007/s10549-011-1359-821287362Search in Google Scholar

13. Davis WG, Hennessy B, Babiera G, Hunt K, Valero V, Buchholz TA et al: Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol. 2005 Nov;29(11):1456-63.10.1097/01.pas.0000176431.96326.4916224212Search in Google Scholar

14. Gibson G.R., Qian D., Ku J.K., et al. Metaplastic breast cancer: clinical features and outcomes, Am. Surg. 71 (2005) 725-730Search in Google Scholar

15. .Weigelt B, Kreike B, Reis-Filho JS.: Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat. 2009 Sep;117(2):273-80. Epub 2008 Sep 25.10.1007/s10549-008-0197-918815879Search in Google Scholar

16. Gutman H, Poouck RE, Janjan NA et al: Biologic distinction and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg. 1995; 180: 193-199Search in Google Scholar

17. Tseng WH, Martinez SR.: Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol. 2011 Jan;18(1):94-10310.1245/s10434-010-1198-6301825920585866Search in Google Scholar

18. Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA et al: Response to neoadjuvant therapy and longterm survival in patients with triple-negative breast cancer. J Clin Oncol. 2008 Mar 10;26(8):1275-8110.1200/JCO.2007.14.414718250347Search in Google Scholar

19. Leibl S., Moinfar F.: Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J.Clin.Pathol., 2005; 58: 700-704Search in Google Scholar